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seltamivir, a neuraminidase inhibitor, plays a key role in
he management of inﬂuenza. The most commonly reported
dverse effect of oseltamivir is gastrointestinal discomfort
ncluding nausea and vomiting.1,2 Here we report a case
f enterorrhagia, a rare and neglected adverse effect after
seltamivir use.
A twelve year old boy was at day four of empiric
reatment for Inﬂuenza infection and began to experience
ematochezia. His mother brings him to the Emergency
epartment reporting four episodes of anal bleeding. Phys-
cal examination was normal and there were no signs of
emodynamic commitment. Laboratorial screening was per-
ormed and no abnormalities were seen. Hematocrit was
3.1%, hemoglobin 14.8 g/dL (NR: 13.5–17.5 g/dL), platelets
75,000 (NR: 150,000–450,000), RNI 1.14 and creatinine 0.84 (NR:
.5–1.5). The child had no prior history of diseases, surgery
r medication use and had a proper development to his age.
he treatment was suspended, hematochezia ceded and the
atient was full recovered.
Brazil is experimenting a rise in the incidence of inﬂuenza
ases. In 2015, 30% of ﬂu syndromes were caused by inﬂuenza
irus with 1.8% of inﬂuenza A(H1N1)pdm09. This year how-
ver, inﬂuenza virus is responsible for 78.5% of ﬂu syndrome
nd inﬂuenza A(H1N1)pdm09 for 70.9% of them.3,4 This data
akes the clinician alert to the problem and prompt to pre-
cribe oseltamivir when facing a ﬂu syndrome.
We are aware of controversial on the literature about the
fﬁcacy of oseltamivir.5 In a developing country scenario, con-
rmatory tests for H1N1 are not available everywhere. The
linician must be aware of adverse events and consider the
isk-beneﬁt of treatment before prescription.onﬂicts  of  interest
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